MODV Quote, Financials, Valuation and Earnings

Humana has a net margin of -3.79% compared to ModivCare's net margin of 1.63%. ModivCare's return on equity of -206.4% beat Humana's return on equity of 8.1%.

ModivCare has a consensus price target of --, signalling upside risk potential of 130.61%. On the other hand Humana has an analysts' consensus of $287.90 which suggests that it could grow by 16.51%. Given that ModivCare has higher upside potential than Humana, analysts believe ModivCare is more attractive than Humana.

ModivCare has a beta of 0.535, which suggesting that the stock is 46.467% less volatile than S&P 500. In comparison Humana has a beta of 0.532, suggesting its less volatile than the S&P 500 by 46.758%.

ModivCare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humana offers a yield of 1.43% to investors and pays a quarterly dividend of $0.89 per share. ModivCare pays -- of its earnings as a dividend. Humana pays out 17.32% of its earnings as a dividend. Humana's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

ModivCare quarterly revenues are $702M, which are smaller than Humana quarterly revenues of $29.4B. ModivCare's net income of -$26.6M is lower than Humana's net income of $480M. Notably, ModivCare's price-to-earnings ratio is -- while Humana's PE ratio is 21.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ModivCare is 0.06x versus 0.26x for Humana. Usually stocks with elevated PS ratios are considered overvalued.

Marpai has a net margin of -3.79% compared to ModivCare's net margin of -58.85%. ModivCare's return on equity of -206.4% beat Marpai's return on equity of --.

ModivCare has a consensus price target of --, signalling upside risk potential of 130.61%. On the other hand Marpai has an analysts' consensus of -- which suggests that it could fall by --. Given that ModivCare has higher upside potential than Marpai, analysts believe ModivCare is more attractive than Marpai.

ModivCare has a beta of 0.535, which suggesting that the stock is 46.467% less volatile than S&P 500. In comparison Marpai has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

ModivCare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Marpai offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ModivCare pays -- of its earnings as a dividend. Marpai pays out -- of its earnings as a dividend.

ModivCare quarterly revenues are $702M, which are larger than Marpai quarterly revenues of $7.4M. ModivCare's net income of -$26.6M is lower than Marpai's net income of -$4.3M. Notably, ModivCare's price-to-earnings ratio is -- while Marpai's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ModivCare is 0.06x versus 0.22x for Marpai. Usually stocks with elevated PS ratios are considered overvalued.

Regional Health Properties has a net margin of -3.79% compared to ModivCare's net margin of -23.24%. ModivCare's return on equity of -206.4% beat Regional Health Properties's return on equity of -489.72%.

ModivCare has a consensus price target of --, signalling upside risk potential of 130.61%. On the other hand Regional Health Properties has an analysts' consensus of -- which suggests that it could grow by 330.46%. Given that Regional Health Properties has higher upside potential than ModivCare, analysts believe Regional Health Properties is more attractive than ModivCare.

ModivCare has a beta of 0.535, which suggesting that the stock is 46.467% less volatile than S&P 500. In comparison Regional Health Properties has a beta of 0.916, suggesting its less volatile than the S&P 500 by 8.446%.

ModivCare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Regional Health Properties offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ModivCare pays -- of its earnings as a dividend. Regional Health Properties pays out -- of its earnings as a dividend.

ModivCare quarterly revenues are $702M, which are larger than Regional Health Properties quarterly revenues of $4.2M. ModivCare's net income of -$26.6M is lower than Regional Health Properties's net income of -$982K. Notably, ModivCare's price-to-earnings ratio is -- while Regional Health Properties's PE ratio is 0.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ModivCare is 0.06x versus 0.16x for Regional Health Properties. Usually stocks with elevated PS ratios are considered overvalued.

Talkspace has a net margin of -3.79% compared to ModivCare's net margin of 3.95%. ModivCare's return on equity of -206.4% beat Talkspace's return on equity of -1.17%.

ModivCare has a consensus price target of --, signalling upside risk potential of 130.61%. On the other hand Talkspace has an analysts' consensus of $4.00 which suggests that it could grow by 63.59%. Given that ModivCare has higher upside potential than Talkspace, analysts believe ModivCare is more attractive than Talkspace.

ModivCare has a beta of 0.535, which suggesting that the stock is 46.467% less volatile than S&P 500. In comparison Talkspace has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

ModivCare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Talkspace offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ModivCare pays -- of its earnings as a dividend. Talkspace pays out -- of its earnings as a dividend.

ModivCare quarterly revenues are $702M, which are larger than Talkspace quarterly revenues of $47.4M. ModivCare's net income of -$26.6M is lower than Talkspace's net income of $1.9M. Notably, ModivCare's price-to-earnings ratio is -- while Talkspace's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ModivCare is 0.06x versus 2.79x for Talkspace. Usually stocks with elevated PS ratios are considered overvalued.